EKF Diagnostics (LON:EKF) Share Price Crosses Below 200-Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 27.14 and traded as low as GBX 24.80. EKF Diagnostics shares last traded at GBX 25.60, with a volume of 103,818 shares trading hands.

EKF Diagnostics Stock Down 0.4%

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of £110.15 million, a PE ratio of 18.89 and a beta of 0.57. The firm’s fifty day moving average is GBX 25.43 and its 200-day moving average is GBX 27.14.

Insider Activity

In other EKF Diagnostics news, insider Julian Baines purchased 85,000 shares of EKF Diagnostics stock in a transaction dated Monday, December 15th. The stock was acquired at an average cost of GBX 23 per share, with a total value of £19,550. Company insiders own 39.72% of the company’s stock.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.